XML 23 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
2. Segment Information and Concentrations (Tables)
9 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Segment Information
  Benchtop Laboratory Equipment Catalyst Research Instruments Bioprocessing Systems Corporate And Other Consolidated
Three Months Ended March 31, 2018:          
           
Revenues $1,550,700 $110,700 $437,900 $- $2,099,300
           
Foreign Sales 620,200 105,400 - - 725,600
           

Income (Loss) From

Operations

78,200 (74,400) (87,700) - (83,900)
           
Assets 3,930,600 1,680,800 893,300 853,600 7,358,300
           

Long-Lived Asset

Expenditures

4,500 - - - 4,500
           

Depreciation and

Amortization

67,400 (800) 9,400 -       76,000

  

  Benchtop Laboratory Equipment Catalyst Research Instruments Bioprocessing Systems Corporate And Other Consolidated
Three Months Ended March 31, 2017:          
           
Revenues $1,410,800 $359,800 $140,300 $- $1,910,900
           
Foreign Sales 611,400 37,100 - - 648,500
           

Income (Loss) From

Operations

88,900 (82,400) 76,500 - 83,000
           
Assets 4,170,900 1,822,200 485,700 719,200 7,198,000
           

Long-Lived Asset

Expenditures

4,600 - 7,000 - 11,600
           

Depreciation and

Amortization

73,500 1,600 12,000 - 87,100

  

  Benchtop Laboratory Equipment Catalyst Research Instruments Bioprocessing Systems Corporate And Other Consolidated
Nine Months Ended March 31, 2018:          
           
Revenues $4,436,300 $293,000 $543,300 $- $5,272,600
           
Foreign Sales 1,937,800 114,400 - - 2,052,200
           

Income (Loss) From

Operations

106,300 (361,900) (124,900) - (380,500)
           
Assets 3,930,600 1,680,800 893,300 853,600 7,358,300
           

Long-Lived Asset

Expenditures

69,700 1,900 2,500 - 74,100
           

Depreciation and

Amortization

199,300 2,700 28,100 - 230,100

  

  Benchtop Laboratory Equipment Catalyst Research Instruments Bioprocessing Systems Corporate And Other Consolidated
Nine Months Ended March 31, 2017:          
           
Revenues $4,334,400 $1,629,400 $190,000 $- $6,153,800
           
Foreign Sales 1,924,400 52,200 - - 1,976,600
           

Income (Loss) From

Operations

252,900 (197,400) 9,100 - 64,600
           
Assets 4,170,900 1,822,200 485,700 719,200 7,198,000
           

Long-Lived Asset

Expenditures

18,200 - 12,800 - 31,000
           

Depreciation and

Amortization

226,900 12,600 37,000 - 276,500